Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AXGN · against 1,216 other Healthcare companies
Ranked #421 of 1,217 · scores higher than 65% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 60–69, including AXGN · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | AXGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 23.6% | 6.1% | 81% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 19.3% | 5.8% | 80% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 421 | 93.7B KRW (≈$67M) | 65 | 36 | |
| 421 | 2.9B CNY (≈$408M) | 65 | 37 | |
| 421 | 225.8B JPY (≈$1.5B) | 65 | 69 | |
| 421 | 1.2B USD | 65 | 42 | |
| 421 | 2.9B USD | 65 | 44 | |
| 421 | 179.7B INR (≈$2.2B) | 65 | 74 | |
| 421 | 3.6B AUD (≈$2.4B) | 65 | 59 | |
| 421 | 1.1B EUR (≈$1.2B) | 65 | 44 | |
| 421 | 1.2B USD | 65 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score